查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
细胞和基因治疗製造品质控制 (QC) 市场 - 成长、未来前景、竞争分析，2023-2031 年
市场调查报告书
商品编码
1422190

细胞和基因治疗製造品质控制 (QC) 市场 - 成长、未来前景、竞争分析，2023-2031 年

Cell And Gene Therapy Manufacturing Quality Control (QC) Market - Growth, Future Prospects and Competitive Analysis, 2023 - 2031
出版日期: | 出版商: Acute Market Reports | 英文 120 Pages | 商品交期: 最快1-2个工作天内

价格

预计 2024 年至 2032 年期间，细胞和基因治疗製造品质控制 (QC) 市场将以 25% 的复合年增长率成长。细胞和基因疗法生产品质控制 (QC) 在确保细胞和基因疗法的安全性、有效性和一致性方面发挥关键作用。细胞和基因治疗製造品质控制市场是由监管要求、个人化医疗趋势和分析技术进步所推动的。儘管产品特征复杂，但由于细胞和基因疗法的日益普及，市场有望成长。预计设备和配件以及製程开发领域在预测期内将出现强劲成长。从区域来看，亚太地区有扩张机会。该行业领导者的策略专注于技术整合、产能扩张和全面的品质控制解决方案，以满足细胞和基因治疗製造品质控制不断变化的需求。

严格的监管要求

细胞和基因疗法製造品质控制市场是由 FDA 和 EMA 等卫生当局施加的严格监管要求所推动的。监管机构要求采取严格的品质控制措施，以确保细胞和基因疗法符合安全性和有效性标准。例如，FDA 的化学、製造和控制 (CMC) 指南强调彻底的测试、表征和验证，以确保治疗的品质和一致性。监管环境是品质控制基础设施和技术投资的关键驱动力。

个人化医疗的普及

个人化医疗的兴起，即针对个别患者量身定制治疗方案，推动了对稳健品质控製程序的需求。细胞和基因疗法通常是为每位患者量身定制的，需要精确的表征、身份确认和功效测试。随着细胞和基因疗法变得更加主流，品质控制市场对先进分析方法和技术的需求激增，以确保特定治疗的品质和患者安全。

分析技术的进步

高通量定序、质谱和流式细胞仪等分析技术的快速发展改变了品质控制领域。这些技术能够对细胞和基因疗法进行全面的表征和分析，包括遗传组成、纯度和效力。将最先进的分析整合到品质控制流程中不仅可以提高治疗的品质和可靠性，还可以缩短开发和製造时间。

产品特性的复杂性

细胞和基因治疗製造品质控制市场的主要限制因素是产品表征的复杂性。细胞和基因疗法是多方面的，通常包含各种成分，因此难以进行全面的表征。细胞群、基因修饰和治疗机制的异质性需要先进的分析技术来准确评估产品品质。这种复杂性可能会导致更长的品质控制週期和更高的成本。

消耗品按组件占市场主导地位

A市场依组成部分分为设备/配件、消耗品和其他。2023年，耗材占据了最高的销售份额，主要是由于其在细胞治疗和基因治疗QC流程中的持续使用。预计 2024 年至 2032 年预测期内，设备和配件的复合年增长率最高。先进设备和技术的采用，如下一代定序仪和高性能液相层析系统，预计将推动这一成长。

按工艺分，下游工艺主导市场

市场依製程进一步细分为上游製程、下游製程和製程开发。2023年，下游製程收入最高。这是由于需要纯化和分离治疗细胞和遗传物质。然而，预计製程开发将在预测期内实现最高的复合年增长率。专注于优化和扩大製造流程以确保一致的产品品质正在推动对流程开发和相关品质控制策略的投资。

北美仍处于世界领先地位

由于其成熟的细胞和基因治疗生态系统、支持性的监管环境以及重要的研发活动，北美在 2023 年占据了最高的销售份额。然而，预计 2024 年至 2032 年亚太地区的复合年增长率最高。医疗保健基础设施投资的增加、研究合作的增加以及合约製造组织 (CMO) 的出现正在推动该地区 QC 市场的成长。

预测期内市场竞争将加剧

细胞和基因治疗製造品质控制市场的领先公司包括 Lonza Group、Charles River Laboratories、Eurofins Scientific、WuXiAppTec、bioMA(C)rieux SA、Bio-Rad Laboratories, Inc.、Bio-Techne Corporation、QIAGEN、Merck KGaA、这些包括Intertek Group plc、Thermo Fisher Scientific, Inc. 和F. Hoffmann-La Roche Ltd.。这些公司提供广泛的品质控制服务、分析工具和专长，以应对细胞和基因治疗的独特挑战。主要策略包括投资先进的分析技术、扩大测试能力以及提供全面的品质控制解决方案以支援产品开发、製造和法规遵循。该市场的特点是策略联盟和合作伙伴关係，以满足不断变化的品质控制需求。

目录

第一章 前言

  • 报告内容
    • 报告目的
    • 目标听众
    • 主要提供产品
  • 市场细分
  • 调查方法
    • 第一阶段—二次调查
    • 第二阶段-初步调查
    • 第三阶段-专家评审
    • 先决条件
    • 采取的方法

第二章执行摘要

第 3 章 细胞/基因治疗製造品质控制 (QC) 市场：竞争分析

  • 主要供应商的市场地位
  • 供应商采取的策略
  • 主要产业战略
  • 等级分析：2023 年 vs 2032 年

第 4 章 细胞/基因治疗製造品质控制 (QC) 市场：宏观分析与市场动态

  • 介绍
  • 2022-2032 年全球细胞与基因治疗製造品质控制 (QC) 市场价值
  • 市场动态
    • 市场驱动力
    • 市场制约因素
    • 主要问题
    • 主要机会
  • 促进因素和抑制因素的影响分析
  • 跷跷板分析
  • 波特的五力模型
    • 供应商实力
    • 购买力
    • 替代品的威胁
    • 新进入者的威胁
    • 竞争对手之间的竞争
  • PESTEL 分析
    • 政局
    • 金融情况
    • 技术景观
    • 法律状况
    • 社会局势

第 5 章 细胞和基因治疗製造品质控制 (QC) 市场：按组成部分 2022-2032 年

  • 市场概况
  • 成长/利润分析：2023 年与 2032 年
  • 2022-2032年数量和价格分析
  • 市场细分
    • 设备及配件
    • 消耗品
    • 其他

第 6 章 细胞/基因治疗製造品质控制 (QC) 市场：按分析方法 2022-2032

  • 市场概况
  • 成长/利润分析：2023 年与 2032 年
  • 2022-2032年数量和价格分析
  • 市场细分
    • 无菌测试
    • 纯度测试
    • 功效测试
    • 身份测试
    • 其他（稳定性、生存能力等）

第 7 章 细胞/基因治疗製造品质控制 (QC) 市场：按流程划分 2022-2032 年

  • 市场概况
  • 成长/利润分析：2023 年与 2032 年
  • 2022-2032年数量和价格分析
  • 市场细分
    • 上游工艺
    • 下游工艺
    • 工艺开发

第 8 章 细胞/基因治疗製造品质控制 (QC) 市场：按最终用户划分 2022-2032 年

  • 市场概况
  • 成长/利润分析：2023 年与 2032 年
  • 2022-2032年数量和价格分析
  • 市场细分
    • 製药和生物技术公司
    • 合约製造组织

第9章北美细胞和基因治疗製造品质控制（QC）市场2022-2032

  • 市场概况
  • 细胞和基因治疗製造品质控制 (QC) 市场：按组成部分 2022-2032 年
  • 细胞和基因治疗製造品质控制 (QC) 市场：按分析方法 2022-2032
  • 细胞和基因治疗製造品质控制 (QC) 市场：按流程划分 2022-2032 年
  • 细胞和基因治疗製造品质控制 (QC) 市场：按最终用户划分 2022-2032 年
  • 细胞和基因治疗製造品质控制 (QC) 市场：按地区划分 2022-2032 年
    • 北美
      • 美国
      • 加拿大
      • 其他北美

第 10 章英国和欧盟细胞和基因治疗製造品质控制 (QC) 市场 2022-2032

  • 市场概况
  • 细胞和基因治疗製造品质控制 (QC) 市场：按组成部分 2022-2032 年
  • 细胞和基因治疗製造品质控制 (QC) 市场：按分析方法 2022-2032
  • 细胞和基因治疗製造品质控制 (QC) 市场：按流程划分 2022-2032 年
  • 细胞和基因治疗製造品质控制 (QC) 市场：按最终用户划分 2022-2032 年
  • 细胞和基因治疗製造品质控制 (QC) 市场：按地区划分 2022-2032 年
    • 英国和欧盟
      • 英国
      • 德国
      • 西班牙
      • 义大利
      • 法国
      • 欧洲其他地区

第十一章亚太细胞与基因治疗製造品质控制 (QC) 市场 2022-2032

  • 市场概况
  • 细胞和基因治疗製造品质控制 (QC) 市场：按组成部分 2022-2032 年
  • 细胞和基因治疗製造品质控制 (QC) 市场：按分析方法 2022-2032
  • 细胞和基因治疗製造品质控制 (QC) 市场：按流程划分 2022-2032 年
  • 细胞和基因治疗製造品质控制 (QC) 市场：按最终用户划分 2022-2032 年
  • 细胞和基因治疗製造品质控制 (QC) 市场：按地区划分 2022-2032 年
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 亚太其他地区

第十二章拉丁美洲细胞和基因治疗製造品质控制 (QC) 市场 2022-2032

  • 市场概况
  • 细胞和基因治疗製造品质控制 (QC) 市场：按组成部分 2022-2032 年
  • 细胞和基因治疗製造品质控制 (QC) 市场：按分析方法 2022-2032
  • 细胞和基因治疗製造品质控制 (QC) 市场：按流程划分 2022-2032 年
  • 细胞和基因治疗製造品质控制 (QC) 市场：按最终用户划分 2022-2032 年
  • 细胞和基因治疗製造品质控制 (QC) 市场：按地区划分 2022-2032 年
    • 拉丁美洲
      • 巴西
      • 墨西哥
      • 其他拉丁美洲地区

第十三章中东和非洲细胞和基因治疗製造品质控制 (QC) 市场 2022-2032

  • 市场概况
  • 细胞和基因治疗製造品质控制 (QC) 市场：按组成部分 2022-2032 年
  • 细胞和基因治疗製造品质控制 (QC) 市场：按分析方法 2022-2032
  • 细胞和基因治疗製造品质控制 (QC) 市场：按流程划分 2022-2032 年
  • 细胞和基因治疗製造品质控制 (QC) 市场：按最终用户划分 2022-2032 年
  • 细胞和基因治疗製造品质控制 (QC) 市场：按地区划分 2022-2032 年
    • 中东/非洲
      • GCC
      • 非洲
      • 其他中东/非洲地区

第十四章公司简介

  • Lonza Group
  • Charles River Laboratories
  • Eurofins Scientific
  • WuXiAppTec
  • bioMerieux SA
  • Bio-Rad Laboratories Inc.
  • Bio-Techne Corporation
  • QIAGEN
  • Merck KGaA
  • Intertek Group plc
  • Thermo Fisher Scientific Inc.
  • F. Hoffmann-La Roche Ltd.
  • 其他主要公司
Product Code: 140079-01-24

The cell and gene therapy manufacturing quality control (QC) market is expected to grow at a CAGR of 25% during the forecast period of 2024 to 2032. Cell and gene therapy manufacturing quality control (QC)plays a pivotal role in ensuring the safety, efficacy, and consistency of cell and gene therapies. The cell and gene therapy manufacturing QC market is driven by regulatory requirements, personalized medicine trends, and advancements in analytical technologies. Despite the complexity of product characterization, the market is poised for growth due to the increasing adoption of cell and gene therapies. Equipment and accessories and Process Development segments are expected to exhibit significant growth during the forecast period. Geographically, Asia-Pacific presents opportunities for expansion. Industry leaders' strategies focus on technology integration, capacity expansion, and comprehensive QC solutions to address the evolving demands of cell and gene therapy manufacturing quality control.

Stringent Regulatory Requirements

The QC market for cell and gene therapy manufacturing is driven by stringent regulatory requirements imposed by health authorities such as the FDA and EMA. Regulatory agencies demand rigorous quality control measures to ensure that cell and gene therapies meet safety and efficacy standards. For example, the FDA's guidelines for chemistry, manufacturing, and controls (CMC) emphasize thorough testing, characterization, and validation to ensure the quality and consistency of therapies. The regulatory landscape serves as a significant driver for investments in QC infrastructure and technologies.

Growing Adoption of Personalized Medicine

The rise of personalized medicine, wherein therapies are tailored to individual patients, has amplified the demand for robust QC procedures. Cell and gene therapies are often customized for each patient, requiring precise characterization, identity confirmation, and potency testing. As cell and gene therapies become more mainstream, the QC market experiences a surge in demand for advanced analytical methods and technologies to ensure therapy-specific quality and patient safety.

Advancements in Analytical Technologies

Rapid advancements in analytical technologies, such as high-throughput sequencing, mass spectrometry, and flow cytometry, have revolutionized the QC landscape. These technologies enable comprehensive characterization and analysis of cell and gene therapies, including their genetic makeup, purity, and potency. The integration of cutting-edge analytics into QC processes not only enhances the quality and reliability of therapies but also expedites development and manufacturing timelines.

Complexity of Product Characterization

A key restraint in the cell and gene therapy manufacturing QC market is the complexity of product characterization. Cell and gene therapies are often multifaceted and involve various components, making their comprehensive characterization challenging. The heterogeneity of cell populations, genetic modifications, and therapeutic mechanisms necessitates advanced analytical techniques that can accurately assess product quality. This complexity can lead to prolonged QC timelines and increased costs.

Consumables Dominate the Market by Component

A The market is segmented by component into Equipment and accessories, Consumables, and Others. In 2023, Consumables accounted for the highest revenue share, primarily due to their continuous usage in cell and gene therapy QC processes. During the forecast period from 2024 to 2032, Equipment and accessories are projected to exhibit the highest CAGR. The adoption of advanced equipment and technologies, such as next-generation sequencers and high-performance liquid chromatography systems, is expected to drive this growth.

Downstream Processes Dominate the Market by Process

The market is further segmented by process into Upstream Processes, Downstream Processes, and Process Development. In 2023, Downstream Processes generated the highest revenue, attributed to the need for purification and isolation of therapeutic cells and genetic material. However, during the forecast period, Process Development is anticipated to achieve the highest CAGR. The focus on optimizing and scaling up manufacturing processes to ensure consistent product quality is driving investments in process development and associated QC strategies.

North America Remains as the Global Leader

North America held the highest revenue share in 2023, driven by its established cell and gene therapy ecosystem, supportive regulatory environment, and significant research and development activities. However, the Asia-Pacific region is projected to witness the highest CAGR from 2024 to 2032. Increasing investments in healthcare infrastructure, rising research collaborations, and the emergence of contract manufacturing organizations (CMOs) are driving the growth of the QC market in this region.

Market Competition to Intensify during the Forecast Period

Prominent players in the cell and gene therapy manufacturing QC market include Lonza Group, Charles River Laboratories, Eurofins Scientific, WuXiAppTec, bioMA©rieux SA, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, QIAGEN, Merck KGaA, Intertek Group plc, Thermo Fisher Scientific, Inc., and F. Hoffmann-La Roche Ltd. These companies provide a wide array of QC services, analytical tools, and expertise tailored to the unique challenges of cell and gene therapies. Key strategies involve investing in advanced analytical technologies, expanding testing capabilities, and offering comprehensive QC solutions that support product development, manufacturing, and regulatory compliance. The market is characterized by strategic collaborations and partnerships to address evolving QC needs.

Historical & Forecast Period

This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2023 to 2031.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation ofCell And Gene Therapy Manufacturing Quality Control (QC) market are as follows:

  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Cell And Gene Therapy Manufacturing Quality Control (QC) market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Component

    • Equipment & Accessories
    • Consumables
    • Others

Analytical Method

    • Sterility Testing
    • Purity Testing
    • Potency Testing
    • Identity Testing
    • Others (stability, viability, etc.)

Process

    • Upstream Processes
    • Downstream Processes
    • Process Development

End-User

    • Pharmaceutical & Biotechnology Companies
    • Contract Manufacturing Organizations

Region Segment (2021-2031; US$ Million)

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • UK and European Union
    • UK
    • Germany
    • Spain
    • Italy
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Key questions answered in this report:

  • What are the key micro and macro environmental factors that are impacting the growth of Cell And Gene Therapy Manufacturing Quality Control (QC) market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2031.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Cell And Gene Therapy Manufacturing Quality Control (QC) market?
  • Which is the largest regional market for Cell And Gene Therapy Manufacturing Quality Control (QC) market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Cell And Gene Therapy Manufacturing Quality Control (QC) market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Cell And Gene Therapy Manufacturing Quality Control (QC) market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Cell And Gene Therapy Manufacturing Quality Control (QC) Market
  • 2.2. Global Cell And Gene Therapy Manufacturing Quality Control (QC) Market, By Component, 2023 (US$ Million)
  • 2.3. Global Cell And Gene Therapy Manufacturing Quality Control (QC) Market, By Analytical Method, 2023 (US$ Million)
  • 2.4. Global Cell And Gene Therapy Manufacturing Quality Control (QC) Market, By Process, 2023 (US$ Million)
  • 2.5. Global Cell And Gene Therapy Manufacturing Quality Control (QC) Market, By End-User, 2023 (US$ Million)
  • 2.6. Global Cell And Gene Therapy Manufacturing Quality Control (QC) Market, By Geography, 2023 (US$ Million)
  • 2.7. Attractive Investment Proposition by Geography, 2023

3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: Competitive Analysis

  • 3.1. Market Positioning of Key Cell And Gene Therapy Manufacturing Quality Control (QC) Market Vendors
  • 3.2. Strategies Adopted by Cell And Gene Therapy Manufacturing Quality Control (QC) Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2023 Versus 2032

4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Cell And Gene Therapy Manufacturing Quality Control (QC) Market Value, 2022 - 2032, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis
  • 4.6. Porter's Five Force Model
    • 4.6.1. Supplier Power
    • 4.6.2. Buyer Power
    • 4.6.3. Threat Of Substitutes
    • 4.6.4. Threat Of New Entrants
    • 4.6.5. Competitive Rivalry
  • 4.7. PESTEL Analysis
    • 4.7.1. Political Landscape
    • 4.7.2. Economic Landscape
    • 4.7.3. Technology Landscape
    • 4.7.4. Legal Landscape
    • 4.7.5. Social Landscape

5. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2023 Versus 2032
  • 5.3. Volume and Pricing Analysis, 2022-2032
  • 5.4. Market Segmentation
    • 5.4.1. Equipment & Accessories
    • 5.4.2. Consumables
    • 5.4.3. Others

6. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2023 Versus 2032
  • 6.3. Volume and Pricing Analysis, 2022-2032
  • 6.4. Market Segmentation
    • 6.4.1. Sterility Testing
    • 6.4.2. Purity Testing
    • 6.4.3. Potency Testing
    • 6.4.4. Identity Testing
    • 6.4.5. Others (stability, viability, etc.)

7. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)

  • 7.1. Market Overview
  • 7.2. Growth & Revenue Analysis: 2023 Versus 2032
  • 7.3. Volume and Pricing Analysis, 2022-2032
  • 7.4. Market Segmentation
    • 7.4.1. Upstream Processes
    • 7.4.2. Downstream Processes
    • 7.4.3. Process Development

8. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)

  • 8.1. Market Overview
  • 8.2. Growth & Revenue Analysis: 2023 Versus 2032
  • 8.3. Volume and Pricing Analysis, 2022-2032
  • 8.4. Market Segmentation
    • 8.4.1. Pharmaceutical & Biotechnology Companies
    • 8.4.2. Contract Manufacturing Organizations

9. North America Cell And Gene Therapy Manufacturing Quality Control (QC) Market, 2022-2032, USD (Million)

  • 9.1. Market Overview
  • 9.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
  • 9.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
  • 9.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
  • 9.5. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
  • 9.6.Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Region, 2022-2032, USD (Million)
    • 9.6.1.North America
      • 9.6.1.1. U.S.
        • 9.6.1.1.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
        • 9.6.1.1.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
        • 9.6.1.1.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
        • 9.6.1.1.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
      • 9.6.1.2. Canada
        • 9.6.1.2.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
        • 9.6.1.2.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
        • 9.6.1.2.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
        • 9.6.1.2.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
      • 9.6.1.3. Rest of North America
        • 9.6.1.3.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
        • 9.6.1.3.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
        • 9.6.1.3.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
        • 9.6.1.3.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)

10. UK and European Union Cell And Gene Therapy Manufacturing Quality Control (QC) Market, 2022-2032, USD (Million)

  • 10.1. Market Overview
  • 10.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
  • 10.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
  • 10.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
  • 10.5. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
  • 10.6.Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Region, 2022-2032, USD (Million)
    • 10.6.1.UK and European Union
      • 10.6.1.1. UK
        • 10.6.1.1.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
        • 10.6.1.1.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
        • 10.6.1.1.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
        • 10.6.1.1.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
      • 10.6.1.2. Germany
        • 10.6.1.2.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
        • 10.6.1.2.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
        • 10.6.1.2.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
        • 10.6.1.2.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
      • 10.6.1.3. Spain
        • 10.6.1.3.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
        • 10.6.1.3.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
        • 10.6.1.3.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
        • 10.6.1.3.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
      • 10.6.1.4. Italy
        • 10.6.1.4.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
        • 10.6.1.4.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
        • 10.6.1.4.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
        • 10.6.1.4.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
      • 10.6.1.5. France
        • 10.6.1.5.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
        • 10.6.1.5.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
        • 10.6.1.5.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
        • 10.6.1.5.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
      • 10.6.1.6. Rest of Europe
        • 10.6.1.6.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
        • 10.6.1.6.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
        • 10.6.1.6.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
        • 10.6.1.6.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)

11. Asia Pacific Cell And Gene Therapy Manufacturing Quality Control (QC) Market, 2022-2032, USD (Million)

  • 11.1. Market Overview
  • 11.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
  • 11.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
  • 11.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
  • 11.5. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
  • 11.6.Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Region, 2022-2032, USD (Million)
    • 11.6.1.Asia Pacific
      • 11.6.1.1. China
        • 11.6.1.1.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
        • 11.6.1.1.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
        • 11.6.1.1.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
        • 11.6.1.1.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
      • 11.6.1.2. Japan
        • 11.6.1.2.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
        • 11.6.1.2.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
        • 11.6.1.2.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
        • 11.6.1.2.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
      • 11.6.1.3. India
        • 11.6.1.3.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
        • 11.6.1.3.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
        • 11.6.1.3.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
        • 11.6.1.3.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
      • 11.6.1.4. Australia
        • 11.6.1.4.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
        • 11.6.1.4.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
        • 11.6.1.4.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
        • 11.6.1.4.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
      • 11.6.1.5. South Korea
        • 11.6.1.5.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
        • 11.6.1.5.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
        • 11.6.1.5.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
        • 11.6.1.5.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
      • 11.6.1.6. Rest of Asia Pacific
        • 11.6.1.6.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
        • 11.6.1.6.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
        • 11.6.1.6.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
        • 11.6.1.6.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)

12. Latin America Cell And Gene Therapy Manufacturing Quality Control (QC) Market, 2022-2032, USD (Million)

  • 12.1. Market Overview
  • 12.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
  • 12.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
  • 12.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
  • 12.5. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
  • 12.6.Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Region, 2022-2032, USD (Million)
    • 12.6.1.Latin America
      • 12.6.1.1. Brazil
        • 12.6.1.1.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
        • 12.6.1.1.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
        • 12.6.1.1.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
        • 12.6.1.1.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
      • 12.6.1.2. Mexico
        • 12.6.1.2.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
        • 12.6.1.2.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
        • 12.6.1.2.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
        • 12.6.1.2.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
      • 12.6.1.3. Rest of Latin America
        • 12.6.1.3.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
        • 12.6.1.3.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
        • 12.6.1.3.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
        • 12.6.1.3.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)

13. Middle East and Africa Cell And Gene Therapy Manufacturing Quality Control (QC) Market, 2022-2032, USD (Million)

  • 13.1. Market Overview
  • 13.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
  • 13.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
  • 13.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
  • 13.5. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
  • 13.6.Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Region, 2022-2032, USD (Million)
    • 13.6.1.Middle East and Africa
      • 13.6.1.1. GCC
        • 13.6.1.1.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
        • 13.6.1.1.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
        • 13.6.1.1.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
        • 13.6.1.1.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
      • 13.6.1.2. Africa
        • 13.6.1.2.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
        • 13.6.1.2.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
        • 13.6.1.2.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
        • 13.6.1.2.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
      • 13.6.1.3. Rest of Middle East and Africa
        • 13.6.1.3.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
        • 13.6.1.3.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
        • 13.6.1.3.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
        • 13.6.1.3.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)

14. Company Profile

  • 14.1. Lonza Group
    • 14.1.1. Company Overview
    • 14.1.2. Financial Performance
    • 14.1.3. Product Portfolio
    • 14.1.4. Strategic Initiatives
  • 14.2. Charles River Laboratories
    • 14.2.1. Company Overview
    • 14.2.2. Financial Performance
    • 14.2.3. Product Portfolio
    • 14.2.4. Strategic Initiatives
  • 14.3. Eurofins Scientific
    • 14.3.1. Company Overview
    • 14.3.2. Financial Performance
    • 14.3.3. Product Portfolio
    • 14.3.4. Strategic Initiatives
  • 14.4. WuXiAppTec
    • 14.4.1. Company Overview
    • 14.4.2. Financial Performance
    • 14.4.3. Product Portfolio
    • 14.4.4. Strategic Initiatives
  • 14.5. bioMerieux SA
    • 14.5.1. Company Overview
    • 14.5.2. Financial Performance
    • 14.5.3. Product Portfolio
    • 14.5.4. Strategic Initiatives
  • 14.6. Bio-Rad Laboratories, Inc.
    • 14.6.1. Company Overview
    • 14.6.2. Financial Performance
    • 14.6.3. Product Portfolio
    • 14.6.4. Strategic Initiatives
  • 14.7. Bio-Techne Corporation
    • 14.7.1. Company Overview
    • 14.7.2. Financial Performance
    • 14.7.3. Product Portfolio
    • 14.7.4. Strategic Initiatives
  • 14.8. QIAGEN
    • 14.8.1. Company Overview
    • 14.8.2. Financial Performance
    • 14.8.3. Product Portfolio
    • 14.8.4. Strategic Initiatives
  • 14.9. Merck KGaA
    • 14.9.1. Company Overview
    • 14.9.2. Financial Performance
    • 14.9.3. Product Portfolio
    • 14.9.4. Strategic Initiatives
  • 14.10. Intertek Group plc
    • 14.10.1. Company Overview
    • 14.10.2. Financial Performance
    • 14.10.3. Product Portfolio
    • 14.10.4. Strategic Initiatives
  • 14.11. Thermo Fisher Scientific, Inc.
    • 14.11.1. Company Overview
    • 14.11.2. Financial Performance
    • 14.11.3. Product Portfolio
    • 14.11.4. Strategic Initiatives
  • 14.12. F. Hoffmann-La Roche Ltd.
    • 14.12.1. Company Overview
    • 14.12.2. Financial Performance
    • 14.12.3. Product Portfolio
    • 14.12.4. Strategic Initiatives
  • 14.13. Other Notable Players
    • 14.13.1. Company Overview
    • 14.13.2. Financial Performance
    • 14.13.3. Product Portfolio
    • 14.13.4. Strategic Initiatives

List of Tables

  • TABLE 1 Global Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Component, 2022-2032, USD (Million)
  • TABLE 2 Global Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Analytical Method, 2022-2032, USD (Million)
  • TABLE 3 Global Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Process, 2022-2032, USD (Million)
  • TABLE 4 Global Cell And Gene Therapy Manufacturing Quality Control (QC) Market By End-User, 2022-2032, USD (Million)
  • TABLE 5 North America Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Component, 2022-2032, USD (Million)
  • TABLE 6 North America Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Analytical Method, 2022-2032, USD (Million)
  • TABLE 7 North America Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Process, 2022-2032, USD (Million)
  • TABLE 8 North America Cell And Gene Therapy Manufacturing Quality Control (QC) Market By End-User, 2022-2032, USD (Million)
  • TABLE 9 U.S. Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Component, 2022-2032, USD (Million)
  • TABLE 10 U.S. Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Analytical Method, 2022-2032, USD (Million)
  • TABLE 11 U.S. Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Process, 2022-2032, USD (Million)
  • TABLE 12 U.S. Cell And Gene Therapy Manufacturing Quality Control (QC) Market By End-User, 2022-2032, USD (Million)
  • TABLE 13 Canada Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Component, 2022-2032, USD (Million)
  • TABLE 14 Canada Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Analytical Method, 2022-2032, USD (Million)
  • TABLE 15 Canada Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Process, 2022-2032, USD (Million)
  • TABLE 16 Canada Cell And Gene Therapy Manufacturing Quality Control (QC) Market By End-User, 2022-2032, USD (Million)
  • TABLE 17 Rest of North America Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Component, 2022-2032, USD (Million)
  • TABLE 18 Rest of North America Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Analytical Method, 2022-2032, USD (Million)
  • TABLE 19 Rest of North America Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Process, 2022-2032, USD (Million)
  • TABLE 20 Rest of North America Cell And Gene Therapy Manufacturing Quality Control (QC) Market By End-User, 2022-2032, USD (Million)
  • TABLE 21 UK and European Union Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Component, 2022-2032, USD (Million)
  • TABLE 22 UK and European Union Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Analytical Method, 2022-2032, USD (Million)
  • TABLE 23 UK and European Union Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Process, 2022-2032, USD (Million)
  • TABLE 24 UK and European Union Cell And Gene Therapy Manufacturing Quality Control (QC) Market By End-User, 2022-2032, USD (Million)
  • TABLE 25 UK Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Component, 2022-2032, USD (Million)
  • TABLE 26 UK Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Analytical Method, 2022-2032, USD (Million)
  • TABLE 27 UK Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Process, 2022-2032, USD (Million)
  • TABLE 28 UK Cell And Gene Therapy Manufacturing Quality Control (QC) Market By End-User, 2022-2032, USD (Million)
  • TABLE 29 Germany Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Component, 2022-2032, USD (Million)
  • TABLE 30 Germany Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Analytical Method, 2022-2032, USD (Million)
  • TABLE 31 Germany Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Process, 2022-2032, USD (Million)
  • TABLE 32 Germany Cell And Gene Therapy Manufacturing Quality Control (QC) Market By End-User, 2022-2032, USD (Million)
  • TABLE 33 Spain Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Component, 2022-2032, USD (Million)
  • TABLE 34 Spain Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Analytical Method, 2022-2032, USD (Million)
  • TABLE 35 Spain Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Process, 2022-2032, USD (Million)
  • TABLE 36 Spain Cell And Gene Therapy Manufacturing Quality Control (QC) Market By End-User, 2022-2032, USD (Million)
  • TABLE 37 Italy Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Component, 2022-2032, USD (Million)
  • TABLE 38 Italy Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Analytical Method, 2022-2032, USD (Million)
  • TABLE 39 Italy Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Process, 2022-2032, USD (Million)
  • TABLE 40 Italy Cell And Gene Therapy Manufacturing Quality Control (QC) Market By End-User, 2022-2032, USD (Million)
  • TABLE 41 France Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Component, 2022-2032, USD (Million)
  • TABLE 42 France Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Analytical Method, 2022-2032, USD (Million)
  • TABLE 43 France Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Process, 2022-2032, USD (Million)
  • TABLE 44 France Cell And Gene Therapy Manufacturing Quality Control (QC) Market By End-User, 2022-2032, USD (Million)
  • TABLE 45 Rest of Europe Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Component, 2022-2032, USD (Million)
  • TABLE 46 Rest of Europe Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Analytical Method, 2022-2032, USD (Million)
  • TABLE 47 Rest of Europe Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Process, 2022-2032, USD (Million)
  • TABLE 48 Rest of Europe Cell And Gene Therapy Manufacturing Quality Control (QC) Market By End-User, 2022-2032, USD (Million)
  • TABLE 49 Asia Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Component, 2022-2032, USD (Million)
  • TABLE 50 Asia Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Analytical Method, 2022-2032, USD (Million)
  • TABLE 51 Asia Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Process, 2022-2032, USD (Million)
  • TABLE 52 Asia Cell And Gene Therapy Manufacturing Quality Control (QC) Market By End-User, 2022-2032, USD (Million)
  • TABLE 53 China Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Component, 2022-2032, USD (Million)
  • TABLE 54 China Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Analytical Method, 2022-2032, USD (Million)
  • TABLE 55 China Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Process, 2022-2032, USD (Million)
  • TABLE 56 China Cell And Gene Therapy Manufacturing Quality Control (QC) Market By End-User, 2022-2032, USD (Million)
  • TABLE 57 Japan Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Component, 2022-2032, USD (Million)
  • TABLE 58 Japan Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Analytical Method, 2022-2032, USD (Million)
  • TABLE 59 Japan Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Process, 2022-2032, USD (Million)
  • TABLE 60 Japan Cell And Gene Therapy Manufacturing Quality Control (QC) Market By End-User, 2022-2032, USD (Million)
  • TABLE 61 India Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Component, 2022-2032, USD (Million)
  • TABLE 62 India Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Analytical Method, 2022-2032, USD (Million)
  • TABLE 63 India Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Process, 2022-2032, USD (Million)
  • TABLE 64 India Cell And Gene Therapy Manufacturing Quality Control (QC) Market By End-User, 2022-2032, USD (Million)
  • TABLE 65 Australia Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Component, 2022-2032, USD (Million)
  • TABLE 66 Australia Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Analytical Method, 2022-2032, USD (Million)
  • TABLE 67 Australia Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Process, 2022-2032, USD (Million)
  • TABLE 68 Australia Cell And Gene Therapy Manufacturing Quality Control (QC) Market By End-User, 2022-2032, USD (Million)
  • TABLE 69 South Korea Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Component, 2022-2032, USD (Million)
  • TABLE 70 South Korea Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Analytical Method, 2022-2032, USD (Million)
  • TABLE 71 South Korea Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Process, 2022-2032, USD (Million)
  • TABLE 72 South Korea Cell And Gene Therapy Manufacturing Quality Control (QC) Market By End-User, 2022-2032, USD (Million)
  • TABLE 73 Latin America Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Component, 2022-2032, USD (Million)
  • TABLE 74 Latin America Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Analytical Method, 2022-2032, USD (Million)
  • TABLE 75 Latin America Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Process, 2022-2032, USD (Million)
  • TABLE 76 Latin America Cell And Gene Therapy Manufacturing Quality Control (QC) Market By End-User, 2022-2032, USD (Million)
  • TABLE 77 Brazil Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Component, 2022-2032, USD (Million)
  • TABLE 78 Brazil Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Analytical Method, 2022-2032, USD (Million)
  • TABLE 79 Brazil Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Process, 2022-2032, USD (Million)
  • TABLE 80 Brazil Cell And Gene Therapy Manufacturing Quality Control (QC) Market By End-User, 2022-2032, USD (Million)
  • TABLE 81 Mexico Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Component, 2022-2032, USD (Million)
  • TABLE 82 Mexico Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Analytical Method, 2022-2032, USD (Million)
  • TABLE 83 Mexico Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Process, 2022-2032, USD (Million)
  • TABLE 84 Mexico Cell And Gene Therapy Manufacturing Quality Control (QC) Market By End-User, 2022-2032, USD (Million)
  • TABLE 85 Rest of Latin America Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Component, 2022-2032, USD (Million)
  • TABLE 86 Rest of Latin America Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Analytical Method, 2022-2032, USD (Million)
  • TABLE 87 Rest of Latin America Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Process, 2022-2032, USD (Million)
  • TABLE 88 Rest of Latin America Cell And Gene Therapy Manufacturing Quality Control (QC) Market By End-User, 2022-2032, USD (Million)
  • TABLE 89 Middle East and Africa Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Component, 2022-2032, USD (Million)
  • TABLE 90 Middle East and Africa Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Analytical Method, 2022-2032, USD (Million)
  • TABLE 91 Middle East and Africa Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Process, 2022-2032, USD (Million)
  • TABLE 92 Middle East and Africa Cell And Gene Therapy Manufacturing Quality Control (QC) Market By End-User, 2022-2032, USD (Million)
  • TABLE 93 GCC Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Component, 2022-2032, USD (Million)
  • TABLE 94 GCC Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Analytical Method, 2022-2032, USD (Million)
  • TABLE 95 GCC Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Process, 2022-2032, USD (Million)
  • TABLE 96 GCC Cell And Gene Therapy Manufacturing Quality Control (QC) Market By End-User, 2022-2032, USD (Million)
  • TABLE 97 Africa Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Component, 2022-2032, USD (Million)
  • TABLE 98 Africa Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Analytical Method, 2022-2032, USD (Million)
  • TABLE 99 Africa Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Process, 2022-2032, USD (Million)
  • TABLE 100 Africa Cell And Gene Therapy Manufacturing Quality Control (QC) Market By End-User, 2022-2032, USD (Million)
  • TABLE 101 Rest of Middle East and Africa Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Component, 2022-2032, USD (Million)
  • TABLE 102 Rest of Middle East and Africa Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Analytical Method, 2022-2032, USD (Million)
  • TABLE 103 Rest of Middle East and Africa Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Process, 2022-2032, USD (Million)
  • TABLE 104 Rest of Middle East and Africa Cell And Gene Therapy Manufacturing Quality Control (QC) Market By End-User, 2022-2032, USD (Million)

List of Figures

  • FIG. 1 Global Cell And Gene Therapy Manufacturing Quality Control (QC) Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Cell And Gene Therapy Manufacturing Quality Control (QC) Market: Quality Assurance
  • FIG. 5 Global Cell And Gene Therapy Manufacturing Quality Control (QC) Market, By Component, 2023
  • FIG. 6 Global Cell And Gene Therapy Manufacturing Quality Control (QC) Market, By Analytical Method, 2023
  • FIG. 7 Global Cell And Gene Therapy Manufacturing Quality Control (QC) Market, By Process, 2023
  • FIG. 8 Global Cell And Gene Therapy Manufacturing Quality Control (QC) Market, By End-User, 2023
  • FIG. 9 Global Cell And Gene Therapy Manufacturing Quality Control (QC) Market, By Geography, 2023
  • FIG. 10 Market Geographical Opportunity Matrix - Global Cell And Gene Therapy Manufacturing Quality Control (QC) Market, 2023

FIG. 11Market Positioning of Key Cell And Gene Therapy Manufacturing Quality Control (QC) Market Players, 2023

FIG. 12Global Cell And Gene Therapy Manufacturing Quality Control (QC) Market - Tier Analysis - Percentage of Revenues by Tier Level, 2023 Versus 2032

  • FIG. 13 Global Cell And Gene Therapy Manufacturing Quality Control (QC) Market, By Component, 2023 Vs 2032, %
  • FIG. 14 Global Cell And Gene Therapy Manufacturing Quality Control (QC) Market, By Analytical Method, 2023 Vs 2032, %
  • FIG. 15 Global Cell And Gene Therapy Manufacturing Quality Control (QC) Market, By Process, 2023 Vs 2032, %
  • FIG. 16 Global Cell And Gene Therapy Manufacturing Quality Control (QC) Market, By End-User, 2023 Vs 2032, %
  • FIG. 17 U.S. Cell And Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022 - 2032
  • FIG. 18 Canada Cell And Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022 - 2032
  • FIG. 19 Rest of North America Cell And Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022 - 2032
  • FIG. 20 UK Cell And Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022 - 2032
  • FIG. 21 Germany Cell And Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022 - 2032
  • FIG. 22 Spain Cell And Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022 - 2032
  • FIG. 23 Italy Cell And Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022 - 2032
  • FIG. 24 France Cell And Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022 - 2032
  • FIG. 25 Rest of Europe Cell And Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022 - 2032
  • FIG. 26 China Cell And Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022 - 2032
  • FIG. 27 Japan Cell And Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022 - 2032
  • FIG. 28 India Cell And Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022 - 2032
  • FIG. 29 Australia Cell And Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022 - 2032
  • FIG. 30 South Korea Cell And Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022 - 2032
  • FIG. 31 Rest of Asia Cell And Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022 - 2032
  • FIG. 32 Brazil Cell And Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022 - 2032
  • FIG. 33 Mexico Cell And Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022 - 2032
  • FIG. 34 Rest of Latin America Cell And Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022 - 2032
  • FIG. 35 GCC Cell And Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022 - 2032
  • FIG. 36 Africa Cell And Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022 - 2032
  • FIG. 37 Rest of Middle East and Africa Cell And Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022 - 2032